These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8759752)

  • 1. Cytokine activation sensitizes human monocytic and endothelial cells to the cytotoxic effects of an anti-CD40 immunotoxin.
    Francisco JA; Kiener PA; Moran-Davis P; Ledbetter JA; Siegall CB
    J Immunol; 1996 Aug; 157(4):1652-8. PubMed ID: 8759752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen.
    Francisco JA; Gilliland LK; Stebbins MR; Norris NA; Ledbetter JA; Siegall CB
    Cancer Res; 1995 Jul; 55(14):3099-104. PubMed ID: 7541711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
    Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction, expression, and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein bryodin 1.
    Francisco JA; Gawlak SL; Siegall CB
    J Biol Chem; 1997 Sep; 272(39):24165-9. PubMed ID: 9305866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines.
    Musso T; Deaglio S; Franco L; Calosso L; Badolato R; Garbarino G; Dianzani U; Malavasi F
    J Leukoc Biol; 2001 Apr; 69(4):605-12. PubMed ID: 11310847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor.
    Kreitman RJ; Schneider WP; Queen C; Tsudo M; Fitzgerald DJ; Waldmann TA; Pastan I
    J Immunol; 1992 Oct; 149(8):2810-5. PubMed ID: 1401913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy and toxicity of a single-chain immunotoxin targeted to CD40.
    Francisco JA; Schreiber GJ; Comereski CR; Mezza LE; Warner GL; Davidson TJ; Ledbetter JA; Siegall CB
    Blood; 1997 Jun; 89(12):4493-500. PubMed ID: 9192773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts.
    Friedman PN; Chace DF; Trail PA; Siegall CB
    J Immunol; 1993 Apr; 150(7):3054-61. PubMed ID: 8454873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of recombinant Fab and Fv immunotoxins on adult T-cell leukemia lymph node and blood cells in the presence of soluble interleukin-2 receptor.
    Saito T; Kreitman RJ; Hanada S; Makino T; Utsunomiya A; Sumizawa T; Arima T; Chang CN; Hudson D; Pastan I
    Cancer Res; 1994 Feb; 54(4):1059-64. PubMed ID: 8313362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes.
    Danis VA; Franic GM; Rathjen DA; Brooks PM
    Clin Exp Immunol; 1991 Jul; 85(1):143-50. PubMed ID: 1906383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.
    Alderson MR; Armitage RJ; Tough TW; Strockbine L; Fanslow WC; Spriggs MK
    J Exp Med; 1993 Aug; 178(2):669-74. PubMed ID: 7688031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells.
    Friedman PN; McAndrew SJ; Gawlak SL; Chace D; Trail PA; Brown JP; Siegall CB
    Cancer Res; 1993 Jan; 53(2):334-9. PubMed ID: 8417827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant GM-CSF-PE40 ligand toxin is functionally active but not cytotoxic to cells.
    O'Brien P; Smythe A; Biggs JC; Smith GM
    Immunol Cell Biol; 1997 Jun; 75(3):289-94. PubMed ID: 9243295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterization of BR96 sFv-PE40. A single-chain immunotoxin fusion protein that cures human breast carcinoma xenografts in athymic mice and rats.
    Siegall CB; Chace D; Mixan B; Garrigues U; Wan H; Paul L; Wolff E; Hellström I; Hellström KE
    J Immunol; 1994 Mar; 152(5):2377-84. PubMed ID: 8133048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
    Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
    Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy of carcinomas using BR96 sFv-PE40, a single-chain immunotoxin that binds to the Le(y) antigen.
    Siegall CB
    Semin Cancer Biol; 1995 Oct; 6(5):289-95. PubMed ID: 8562906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BR96 sFv-PE40 immunotoxin: nonclinical safety assessment.
    Haggerty HG; Warner WA; Comereski CR; Peden WM; Mezza LE; Damle BD; Siegall CB; Davidson TJ
    Toxicol Pathol; 1999; 27(1):87-94. PubMed ID: 10367679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.
    Kylanpaa ML; Mentula P; Kemppainen E; Puolakkainen P; Aittomaki S; Silvennoinen O; Haapiainen R; Repo H
    Pancreas; 2005 Jul; 31(1):23-7. PubMed ID: 15968243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosis.
    Sokolova E; Guryev E; Yudintsev A; Vodeneev V; Deyev S; Balalaeva I
    Oncotarget; 2017 Mar; 8(13):22048-22058. PubMed ID: 28423549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.